Lalwani Nikhil
PRESIDENT & CEO
Lalwani Nikhil has filed 8 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 8 of those filings fall inside the rolling window. Most recent filing: Oct 16, 2026.
On the most recent filing, Lalwani Nikhil is listed as PRESIDENT & CEO at ANI PHARMACEUTICALS INC. Inside the rolling window, Lalwani Nikhil reported no open-market purchases and 4 open-market sales totaling $5.4M in ANIP. The largest disclosed transaction in the window is a sale of 55,000 ANIP shares on May 11, 2026, worth $4.3M.
Companies traded
Other insiders at ANIP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lalwani Nikhil made?
Lalwani Nikhil has filed 8 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does Lalwani Nikhil trade?
Lalwani Nikhil has filed SEC Form 4 disclosures for 1 company, including ANIP.
When was Lalwani Nikhil's most recent SEC Form 4 filing?
Lalwani Nikhil's most recent SEC Form 4 filing on Tracefour is dated Oct 16, 2026.
What is Lalwani Nikhil's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lalwani Nikhil is listed as PRESIDENT & CEO.
What is Lalwani Nikhil's total buy and sell value in the current window?
Inside the rolling retention window, Lalwani Nikhil bought $0 and sold $5.4M based on SEC Form 4 filings.
What was Lalwani Nikhil's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 55,000 ANIP shares on 2026-05-11, worth $4.3M, per SEC Form 4 filings.